TRAVERE THERAPEUTICS, INC. (TVTX)

SEC filing

TRAVERE THERAPEUTICS, INC.

TVTX · CIK 1438533

4 · Sep 17, 2026 · Director, CHIEF EXECUTIVE OFFICER Dube Eric M sold 400K shares at $63.48/share ($25.4M); exercised options for 800K shares

Director, CHIEF EXECUTIVE OFFICER Dube Eric M sold 400K shares at $63.48/share ($25.4M); exercised options for 800K shares

xslF345X06/form4-09182026_010928.xml

xslF345X06/form4-09182026_010928.xmlSEC.gov

Graphics and non-inline formats (not embedded below).